{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:03:25Z","timestamp":1792699405048,"version":"4.5.0"},"reference-count":33,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2019,10,8]]},"DOI":"10.3233\/cbm-190201","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T13:37:35Z","timestamp":1563889055000},"page":"139-150","source":"Crossref","is-referenced-by-count":18,"title":["Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma"],"prefix":"10.1177","volume":"26","author":[{"given":"Xiaolu","family":"Ren","sequence":"first","affiliation":[{"name":"Shanxi Medical University, Taiyuan, Shanxi, China"},{"name":"Shanxi Cancer Hospital, Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanxi Cancer Hospital, Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lyu","sequence":"additional","affiliation":[{"name":"First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoli","family":"Jin","sequence":"additional","affiliation":[{"name":"Shanxi Cancer Hospital, Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Guo","sequence":"additional","affiliation":[{"name":"Shanxi Dayi Hospital, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"Shanxi Cancer Hospital, Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[{"name":"Shanxi Cancer Hospital, Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanxi Medical University, Taiyuan, Shanxi, China"},{"name":"First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-190201_ref1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMc1415359","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer","volume":"372","author":"Arnaoutakis","year":"2015","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-190201_ref2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2407-9-119","article-title":"Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: A prospective analysis","volume":"9","author":"Arrieta","year":"2009","journal-title":"BMC Cancer"},{"key":"10.3233\/CBM-190201_ref3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/CBM-170885","article-title":"Prognostic value of baseline carcinoembryonic antigen and cytokeratin 19 fragment levels in advanced non-small cell lung cancer","volume":"22","author":"Baek","year":"2018","journal-title":"Cancer Biomark"},{"key":"10.3233\/CBM-190201_ref4","first-page":"9820","article-title":"Diagnostic value of CYFRA21-1 and CEA for predicting lymph node metastasis in operable lung cancer","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.3233\/CBM-190201_ref5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.7150\/jca.22305","article-title":"Elevated baseline serum lactate dehydrogenase indicates a poor prognosis in primary duodenum adenocarcinoma patients","volume":"9","author":"Chen","year":"2018","journal-title":"J Cancer"},{"key":"10.3233\/CBM-190201_ref6","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1373\/clinchem.2008.105494","article-title":"National academy of clinical biochemistry laboratory medicine practice guidelines for the use of tumor markers","volume":"54","author":"Diamandis","year":"2008","journal-title":"Clin Chem"},{"key":"10.3233\/CBM-190201_ref7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMoa1411817","article-title":"AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer","volume":"372","author":"Janne","year":"2015","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-190201_ref8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5301\/JBM.5000023","article-title":"Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer","volume":"28","author":"Jiexian","year":"2013","journal-title":"Int J Biol Markers"},{"key":"10.3233\/CBM-190201_ref9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1746-1596-5-22","article-title":"Lactate-dehydrogenase 5 is overexpressed in non-small cell lung cancer and correlates with the expression of the transketolase-like protein 1","volume":"5","author":"Kayser","year":"2010","journal-title":"Diagn Pathol"},{"key":"10.3233\/CBM-190201_ref10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clinbiochem.2018.05.001","article-title":"Triple test with tumor markers CYFRA21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer","volume":"58","author":"Korkmaz","year":"2018","journal-title":"Clin Biochem"},{"key":"10.3233\/CBM-190201_ref11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7150\/jca.9871","article-title":"Serum carcinoembryonic antigen levels and the risk of whole-body metastatic potential in advanced non-small cell lung cancer","volume":"5","author":"Lee","year":"2014","journal-title":"J Cancer"},{"key":"10.3233\/CBM-190201_ref12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s13277-015-3776-5","article-title":"Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: Predictive value of metastases and relation to survival outcomes","volume":"37","author":"Lee","year":"2016","journal-title":"Tumour Biol"},{"key":"10.3233\/CBM-190201_ref13","doi-asserted-by":"crossref","first-page":"e0182168","DOI":"10.1371\/journal.pone.0182168","article-title":"Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"key":"10.3233\/CBM-190201_ref14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cca.2018.03.038","article-title":"The prognostic role of programmed cell death-ligand 1 expression in non-small cell lung cancer patients: An updated meta-analysis","volume":"482","author":"Ma","year":"2018","journal-title":"Clin Chim Acta"},{"key":"10.3233\/CBM-190201_ref15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.lungcan.2015.09.011","article-title":"Plasma biomarker signature associated with improved survival in advanced non-small cell lung cancer patients on linifanib","volume":"90","author":"McKeegan","year":"2015","journal-title":"Lung Cancer"},{"key":"10.3233\/CBM-190201_ref16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1164\/rccm.201404-0603OC","article-title":"Assessment of a combined panel of six serum tumor markers for lung cancer","volume":"193","author":"Molina","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.3233\/CBM-190201_ref17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10585-017-9861-y","article-title":"Current chemotherapeutic regimens for brain metastases treatment","volume":"34","author":"Nam","year":"2017","journal-title":"Clin Exp Metastasis"},{"key":"10.3233\/CBM-190201_ref18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jtho.2017.08.005","article-title":"baseline and on-treatment characteristics of serum tumor markers in stage IV oncogene-addicted adenocarcinoma of the lung","volume":"13","author":"Noonan","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.3233\/CBM-190201_ref19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1164\/rccm.201210-1760OC","article-title":"Biomarkers to help guide management of patients with pulmonary nodules","volume":"188","author":"Patz","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.3233\/CBM-190201_ref20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2016.03.009","article-title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","volume":"45","author":"Peters","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.3233\/CBM-190201_ref21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ijc.11472","article-title":"Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer","volume":"107","author":"Pollan","year":"2003","journal-title":"Int J Cancer"},{"key":"10.3233\/CBM-190201_ref22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJMra1703413","article-title":"Precision diagnosis and treatment for advanced non-small-cell lung cancer","volume":"377","author":"Reck","year":"2017","journal-title":"N Engl J Med"},{"key":"10.3233\/CBM-190201_ref23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jgo.2018.02.011","article-title":"Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer","volume":"9","author":"Sabatier","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.3233\/CBM-190201_ref24","doi-asserted-by":"crossref","unstructured":"C. Scheerens, K. Beernaert, P. Pype, J. Cohen, L. Deliens and K. Chambaere, Comparing the use and timing of palliative care services in COPD and lung cancer: A population-based survey, Eur Respir J 51 (2018).","DOI":"10.1183\/13993003.02405-2017"},{"key":"10.3233\/CBM-190201_ref25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.3233\/CBM-190201_ref26","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 world health organization classification of lung tumors: Impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.3233\/CBM-190201_ref27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/cpt.385","article-title":"The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1\/PD-L1-directed therapy","volume":"100","author":"Villaruz","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.3233\/CBM-190201_ref28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12943-018-0777-1","article-title":"Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer","volume":"17","author":"Wu","year":"2018","journal-title":"Mol Cancer"},{"key":"10.3233\/CBM-190201_ref29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2014.03.003","article-title":"Targeting lactate dehydrogenase \u2013 a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells","volume":"19","author":"Xie","year":"2014","journal-title":"Cell Metab"},{"key":"10.3233\/CBM-190201_ref30","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jamainternmed.2013.1874","article-title":"Early palliative care in advanced lung cancer: A qualitative study","volume":"173","author":"Yoong","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.3233\/CBM-190201_ref31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cca.2016.02.002","article-title":"Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer","volume":"455","author":"Zeng","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.3233\/CBM-190201_ref32","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12885-017-3070-6","article-title":"The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Cancer"},{"key":"10.3233\/CBM-190201_ref33","doi-asserted-by":"crossref","first-page":"20170658","DOI":"10.1259\/bjr.20170658","article-title":"Screening for lung cancer using sub-millisievert chest CT with iterative reconstruction algorithm: Image quality and nodule detectability","volume":"91","author":"Zhang","year":"2018","journal-title":"Br J Radiol"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-190201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:09Z","timestamp":1777385229000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-190201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":33,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-190201","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,8]]}}}